CANAGLIFLOZIN IMPROVES ERYTHROPOIESIS IN DIABETES PATIENTS WITH ANAEMIA OF CHRONIC KIDNEY DISEASE

被引：0
|
作者：
Maruyama, Takashi [1 ]
Takashima, Hiroyuki [1 ]
Abe, Masanori [1 ]
机构：
[1] Nihon Univ, Sch Med, Tokyo, Japan
来源：
NEPHROLOGY | 2020年 / 25卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
467
引用
收藏
页码：72 / 72
页数：1
相关论文
共 50 条
  • [1] Canagliflozin Improves Erythropoiesis in Diabetes Patients with Anemia of Chronic Kidney Disease
    Maruyama, Takashi
    Takashima, Hiroyuki
    Oguma, Hidetaka
    Nakamura, Yoshihiro
    Ohno, Michiko
    Utsunomiya, Kei
    Furukawa, Tetsuya
    Tei, Ritsukou
    Abe, Masanori
    DIABETES TECHNOLOGY & THERAPEUTICS, 2019, 21 (12) : 713 - 720
  • [2] Diabetes mellitus and anaemia in patients with chronic kidney disease
    Lejnieks, A.
    Kuzema, V.
    Petersons, A.
    DIABETOLOGIA, 2008, 51 : S485 - S485
  • [3] An audit of the management of anaemia in patients with diabetes and chronic kidney disease
    Mahawish, L.
    Morris, D.
    Parkinson, C.
    DIABETIC MEDICINE, 2015, 32 : 104 - 104
  • [4] Continuous erythropoiesis receptor activator (CERA) for the anaemia of chronic kidney disease
    Saglimbene, Valeria M.
    Palmer, Suetonia C.
    Ruospo, Marinella
    Natale, Patrizia
    Craig, Jonathan C.
    Strippoli, Giovanni F. M.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2017, (08):
  • [5] Effects of canagliflozin on anaemia in patients with type 2 diabetes and chronic kidney disease: a post-hoc analysis from the CREDENCE trial
    Oshima, Megumi
    Neuen, Brendon L.
    Jardine, Meg J.
    Bakris, George
    Edwards, Robert
    Levin, Adeera
    Mahaffey, Kenneth W.
    Neal, Bruce
    Pollock, Carol
    Rosenthal, Norman
    Wada, Takashi
    Wheeler, David C.
    Perkovic, Vlado
    Heerspink, Hiddo J. L.
    LANCET DIABETES & ENDOCRINOLOGY, 2020, 8 (11): : 903 - 914
  • [6] CANAGLIFLOZIN AND RENAL OUTCOMES IN PATIENTS WITH CHRONIC KIDNEY DISEASE
    Perkovic, V.
    Neuen, B. L.
    Ohkuma, T.
    Neal, B.
    Matthews, D. R.
    de Zeeuw, D.
    Mahaffey, K. W.
    Fulcher, G.
    Desai, M.
    Li, Q.
    Deng, H.
    Rosenthal, N.
    Bakris, G.
    AMERICAN JOURNAL OF KIDNEY DISEASES, 2018, 71 (04) : 574 - 574
  • [7] Canagliflozin and cardiovascular outcomes in patients with chronic kidney disease
    Perkovic, V.
    Neuen, B. L.
    Ohkuma, T.
    Neal, B.
    Matthews, D. R.
    de Zeeuw, D.
    Mahaffey, K. W.
    Fulcher, G.
    Desai, M.
    Li, Q.
    Deng, H.
    Rosenthal, N.
    Jardine, M.
    Bakris, G.
    DIABETOLOGIA, 2018, 61 : S39 - S39
  • [8] Erythropoiesis-stimulating agents for anaemia in chronic kidney disease: are they all the same?
    Mudge, David W.
    Webster, Angela C.
    COCHRANE DATABASE OF SYSTEMATIC REVIEWS, 2014, (12):
  • [9] Erythropoiesis-stimulating agents: Treating the anaemia of chronic kidney disease - Foreword
    Carrera, Fernando
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2007, 22 : 1 - 1
  • [10] Canagliflozin and Cardiovascular (CV) Outcomes in Patients with Chronic Kidney Disease
    Neuen, Brendon L.
    Ohkuma, Toshiaki
    Neal, Bruce
    Matthews, David R.
    Mahaffey, Kenneth W.
    Fulcher, Greg
    Desai, Mehul
    Li, Qiang
    Deng, Hsiaowei
    Rosenthal, Norm
    Jardine, Meg
    Bakris, George
    Perkovic, Vlado
    DIABETES, 2018, 67
12345